SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19
- Autores
- Pirola, Carlos José; Sookoian, Silvia Cristina
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Zhang et al. showed that COVID‐19 affected patients’ present liver biochemistry abnormalities, including elevation of aminotransferases, gamma‐glutamyl transferase, and alkaline phosphatase 1. Hence, several possible clinical scenarios in the setting of liver diseases have been postulated. First, patients with chronic liver disease may be more vulnerable to the severe clinical consequences of COVID‐19, including oxygen desaturation and hypoxemia due to severe pneumonia or the cytokine storm 1;2. Second, liver biochemistry abnormalities are the consequence of drug toxicity.
Fil: Pirola, Carlos José. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina
Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina - Materia
-
COVID-19
HEPATITIS
SARS-CoV-2
TRANSAMINASES - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/106197
Ver los metadatos del registro completo
id |
CONICETDig_814db0e2462b4ca51a9c3459ab469f81 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/106197 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19Pirola, Carlos JoséSookoian, Silvia CristinaCOVID-19HEPATITISSARS-CoV-2TRANSAMINASEShttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Zhang et al. showed that COVID‐19 affected patients’ present liver biochemistry abnormalities, including elevation of aminotransferases, gamma‐glutamyl transferase, and alkaline phosphatase 1. Hence, several possible clinical scenarios in the setting of liver diseases have been postulated. First, patients with chronic liver disease may be more vulnerable to the severe clinical consequences of COVID‐19, including oxygen desaturation and hypoxemia due to severe pneumonia or the cytokine storm 1;2. Second, liver biochemistry abnormalities are the consequence of drug toxicity.Fil: Pirola, Carlos José. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; ArgentinaFil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; ArgentinaWiley Blackwell Publishing, Inc2020-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/106197Pirola, Carlos José; Sookoian, Silvia Cristina; SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19; Wiley Blackwell Publishing, Inc; Liver International; 4-2020; 1-71478-3223CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.14500info:eu-repo/semantics/altIdentifier/doi/10.1111/liv.14500info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:02:08Zoai:ri.conicet.gov.ar:11336/106197instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:02:08.488CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19 |
title |
SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19 |
spellingShingle |
SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19 Pirola, Carlos José COVID-19 HEPATITIS SARS-CoV-2 TRANSAMINASES |
title_short |
SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19 |
title_full |
SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19 |
title_fullStr |
SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19 |
title_full_unstemmed |
SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19 |
title_sort |
SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19 |
dc.creator.none.fl_str_mv |
Pirola, Carlos José Sookoian, Silvia Cristina |
author |
Pirola, Carlos José |
author_facet |
Pirola, Carlos José Sookoian, Silvia Cristina |
author_role |
author |
author2 |
Sookoian, Silvia Cristina |
author2_role |
author |
dc.subject.none.fl_str_mv |
COVID-19 HEPATITIS SARS-CoV-2 TRANSAMINASES |
topic |
COVID-19 HEPATITIS SARS-CoV-2 TRANSAMINASES |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Zhang et al. showed that COVID‐19 affected patients’ present liver biochemistry abnormalities, including elevation of aminotransferases, gamma‐glutamyl transferase, and alkaline phosphatase 1. Hence, several possible clinical scenarios in the setting of liver diseases have been postulated. First, patients with chronic liver disease may be more vulnerable to the severe clinical consequences of COVID‐19, including oxygen desaturation and hypoxemia due to severe pneumonia or the cytokine storm 1;2. Second, liver biochemistry abnormalities are the consequence of drug toxicity. Fil: Pirola, Carlos José. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina |
description |
Zhang et al. showed that COVID‐19 affected patients’ present liver biochemistry abnormalities, including elevation of aminotransferases, gamma‐glutamyl transferase, and alkaline phosphatase 1. Hence, several possible clinical scenarios in the setting of liver diseases have been postulated. First, patients with chronic liver disease may be more vulnerable to the severe clinical consequences of COVID‐19, including oxygen desaturation and hypoxemia due to severe pneumonia or the cytokine storm 1;2. Second, liver biochemistry abnormalities are the consequence of drug toxicity. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-04 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/106197 Pirola, Carlos José; Sookoian, Silvia Cristina; SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19; Wiley Blackwell Publishing, Inc; Liver International; 4-2020; 1-7 1478-3223 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/106197 |
identifier_str_mv |
Pirola, Carlos José; Sookoian, Silvia Cristina; SARS‐CoV‐2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID‐19; Wiley Blackwell Publishing, Inc; Liver International; 4-2020; 1-7 1478-3223 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.14500 info:eu-repo/semantics/altIdentifier/doi/10.1111/liv.14500 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269739574886400 |
score |
13.13397 |